Health Insurance Innovations has been in the news lately because one of the businesses it has done business with was taken over by the FTC after allegations of fraud. HIIQ has disavowed all activities by this rogue distributor and are not of any interest by regulatory agencies.
In fact, Health Innovations recently concluded a 42 state investigation where its business practices were thoroughly examined.
An anonymous stock analyst has recently released one of the most authoritative looks at the Health Insurance Innovations business model in a hard to find post on Scutify.
A number of other research firms have also recently commented on HIIQ.
B. Riley boosted their target price on shares of Health Insurance Innovations from $56.00 to $60.00 and gave the stock a buy rating in a research note on Thursday, September 27th. TheStreet raised shares of Health Insurance Innovations from a c rating to a b- rating in a research note on recently as well.
Lake Street Capital upped their price objective on shares of Health Insurance Innovations from $51.00 to $75.00 and gave the company a buy rating in a research note on Tuesday, October 30th. Craig Hallum raised their price target on shares of Health Insurance Innovations from $58.00 to $65.00 and gave the company a buy rating in a research note on Tuesday, October 30th.
And lastly, ValuEngine lowered shares of Health Insurance Innovations from a strong-buy rating to a buy rating in a report on Tuesday, October 16th.
Three analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of Buy and a consensus price target of $56.78.